By Ethan Covey
A phase 1 trial underway at Baylor College of Medicine, in Houston, is testing whether a topical cream could boost the body’s immune response to the H5N1 influenza vaccine, according to the National Institutes of Health.
Imiquimod cream, which is used commonly to treat genital warts and certain skin cancers, works by activating the body’s innate immune system to fight invading pathogens.
Two recent studies conducted in Hong Kong showed that the cream, when used in